The Strange and Twisted Tale of Hydroxychloroquine. (n.d.). Wired. Retrieved 1 March 2021, from https://www.wired.com/story/hydroxychloroquine-covid-19-strange-twisted-tale/

Niemeyer, H., Aert, R. C. M. van, Schmid, S., Uelsmann, D., Knaevelsrud, C., & Schulte-Herbrueggen, O. (2020). Publication Bias in Meta-Analyses of Posttraumatic Stress Disorder Interventions. Meta-Psychology, 4. https://doi.org/10.15626/MP.2018.884

Ramamurti, R. (2020, October 27). Global Crowdsourcing Can Help the U.S. Beat the Pandemic. Harvard Business Review. https://hbr.org/2020/10/global-crowdsourcing-can-help-the-u-s-beat-the-pandemic

Anderson, R. (2016). The Impact of Vaccination on the Epidemiology of Infectious Diseases. https://doi.org/10.1016/B978-0-12-802174-3.00001-1

Tupper, P., Boury, H., Yerlanov, M., & Colijn, C. (2020). Event-specific interventions to minimize COVID-19 transmission. Proceedings of the National Academy of Sciences, 117(50), 32038–32045. https://doi.org/10.1073/pnas.2019324117

‘Verify before you amplify’: The BAME activists fighting Covid myths. (2021, January 19). The Guardian. http://www.theguardian.com/world/2021/jan/19/verify-before-you-amplify-the-bame-activists-fighting-covid-myths

ReconfigBehSci. (2021, January 15). RT @MaartenvSmeden: The infamous retracted Hydroxychloroquire Lancet article? Cited.... 883 TIMES https://t.co/Zinyel2d8i [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1351111003283578883

Richardson, L., & Crawford, A. (2020, October 27). How Indigenous Communities in Canada Organized an Exemplary Public Health Response to COVID. Scientific American. https://www.scientificamerican.com/article/how-indigenous-communities-in-canada-organized-an-exemplary-public-health-response-to-covid/

Mandavilli, A. (2021, January 28). Some Covid Survivors Have Antibodies That Attack the Body, not Virus. The New York Times. https://www.nytimes.com/2020/10/27/health/covid-antibodies-autoimmunity.html

Nature Editorial. (2020, October 23). The race to make COVID antibody therapies cheaper and more potent. Nature. https://www.nature.com/articles/d41586-020-02965-3?utm_source=twt_nnc&utm_medium=social&utm_campaign=naturenews&sf239165668=1&error=cookies_not_supported&code=2b2dd7c6-d01f-4057-8389-3be656a7ba58

Marshall, M. (2021). COVID’s toll on smell and taste: What scientists do and don’t know. Nature, 589(7842), 342–343. https://doi.org/10.1038/d41586-021-00055-6

Nogués, X., Ovejero, D., Quesada-Gomez, J. M., Bouillon, R., Arenas, D., Pascual, J., Villar-Garcia, J., Rial, A., Gimenez-Argente, C., Cos, M. L., Rodriguez-Morera, J., Campodarve, I., Guerri-Fernandez, R., Pineda-Moncusí, M., & García-Giralt, N. (2021). Calcifediol Treatment and COVID-19-Related Outcomes (SSRN Scholarly Paper ID 3771318). Social Science Research Network. https://doi.org/10.2139/ssrn.3771318

Mori, Makoto, Harlan M. Krumholz, and Heather G. Allore. ‘Using Latent Class Analysis to Identify Hidden Clinical Phenotypes’. JAMA 324, no. 7 (18 August 2020): 700–701. https://doi.org/10.1001/jama.2020.2278.

Schneider, I. K., Dorrough, A. R., & Frank, C. (2021). Ambivalence and Adherence to Measures to Reduce the Spread of COVID-19. PsyArXiv. https://doi.org/10.31234/osf.io/b9hcg

Dyer, C. (2021). Covid 19: How to feel safe working on the front line—your legal and ethical questions answered. BMJ, 372, n179. https://doi.org/10.1136/bmj.n179

Study shows vaccine nationalism could cost rich countries US$4.5 trillion. (2021, January 25). ICC - International Chamber of Commerce. https://iccwbo.org/media-wall/news-speeches/study-shows-vaccine-nationalism-could-cost-rich-countries-us4-5-trillion/

London, Alex John, and Jonathan Kimmelman. ‘Against Pandemic Research Exceptionalism’. Science 368, no. 6490 (1 May 2020): 476–77. https://doi.org/10.1126/science.abc1731.

Tomfohr-Madsen, L., Giesbrecht, G., Lebel, C., Racine, N., & Madigan, S. (2021). Depression and Anxiety in Pregnancy during COVID-19: A Rapid Review and Meta-Analysis. PsyArXiv. https://doi.org/10.31234/osf.io/n8b7x

‘COVID-19 Death Rates Are Going Down, And Not Just Among The Young And Healthy : Shots - Health News : NPR’. Accessed 8 February 2021. https://www.npr.org/sections/health-shots/2020/10/20/925441975/studies-point-to-big-drop-in-covid-19-death-rates?t=1612812595119.

Boseley. S., (2020/06/22). Why doctors say UK is better prepared for second wave of coronavirus. Retrieved from https://www.theguardian.com/world/2020/jun/22/why-doctors-say-uk-better-prepared-for-second-wave-coronavirus?CMP=Share_iOSApp_Other

Bloomberg. (2020). Bloomberg Prognosis: How Covid-19 is Reshaping the Global Healthcare Ecosystem. Retrieved from: https://onlinexperiences.com/scripts/Server.nxp?LASCmd=AI:4;F:QS!10100&ShowUUID=CB925306-099F-4D23-8526-0FDD06AC15C8&LangLocaleID=1033&AffiliateDate=TW

COVID-19 Seminars—Emerging Pathogens Institute—University of Florida. (n.d.). Retrieved January 13, 2021, from https://epi.ufl.edu/covid-19-seminars/

Emily. J. Miller. - FDA {@FDASpox} (2020) Convalescent plasma has shown to be beneficial for 35% of patients. This risk reduction figure - shown in chart below - is from @MayoClinic data from expanded access program that was analyzed by FDAA for the emergency use authorization announced today. Twitter. Retrieved from: https://twitter.com/FDASpox/status/1297706985039835136

Long covid: Diagnosis, management, prognosis. (2020, September 4). https://www.youtube.com/watch?v=zTrIl52jV0s&feature=emb_logo

Dr Nisreen Alwan 🌻 on Twitter. (n.d.). Twitter. Retrieved October 25, 2020, from https://twitter.com/Dr2NisreenAlwan/status/1318078710952714242

Staff, R. (2020, October 5). HIV treatment has no benefit for hospitalised COVID-19 patients: Study. Reuters. https://www.reuters.com/article/us-health-coronavirus-hiv-idUKKBN26Q37E

Thomas, K., & Rabin, R. C. (2020, October 4). Trump’s Treatment Suggests Severe Covid-19, Medical Experts Say. The New York Times. https://www.nytimes.com/2020/10/04/health/trump-covid-treatment.html

MacFarlane, Douglas, Li Qian Tay, Mark J. Hurlstone, and Ullrich Ecker. ‘Refuting Spurious COVID-19 Treatment Claims Reduces Demand and Misinformation Sharing’, 30 September 2020. https://doi.org/10.31234/osf.io/q3mkd.

Haseltine, W. A. (n.d.). Lessons from AIDS for the COVID-19 Pandemic. Scientific American. https://doi.org/10.1038/scientificamerican1020-35

Williams, R., Jenkins, D. A., Ashcroft, D. M., Brown, B., Campbell, S., Carr, M. J., Cheraghi-sohi, S., Kapur, N., Thomas, O., Webb, R. T., & Peek, N. (2020). Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: A retrospective cohort study. The Lancet Public Health, 0(0). https://doi.org/10.1016/S2468-2667(20)30201-2

University Of Pittsburgh Scientists Discover Biomolecule That May Neutralize Coronavirus. (2020, September 15). https://pittsburgh.cbslocal.com/2020/09/15/coronavirus-university-pittsburgh-biomolecule-neutralize/

Siemieniuk, R. A., Bartoszko, J. J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Rochwerg, B., Lamontagne, F., Han, M. A., Liu, Q., Agarwal, A., Agoritsas, T., Chu, D. K., Couban, R., Darzi, A., Devji, T., Fang, B., Fang, C., … Brignardello-Petersen, R. (2020). Drug treatments for covid-19: Living systematic review and network meta-analysis. BMJ, 370. https://doi.org/10.1136/bmj.m2980

Diseases, T. L. I. (2020). Curing COVID-19. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30706-4

Exclusive: In Russia, a black market for HIV drug to try on coronavirus. (2020, April 20). Reuters. https://www.reuters.com/article/us-health-coronavirus-russia-hiv-exclusi-idUSKBN2220W1

Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)31180-6

Tea & Talk Podcast. (2020, June 5). The Royal Society of Edinburgh. https://www.rse.org.uk/publication/tea-talk-podcast/

Coronavirus vaccine safe in early trial, hydroxychloroquine may increase death risk. (2020, May 23). Reuters. https://www.reuters.com/article/us-health-coronavirus-science-idUSKBN22Y2OD

Klein, A. (n.d.). Grief over covid-19 deaths may be unusually severe and long-lasting. New Scientist. Retrieved July 9, 2020, from https://www.newscientist.com/article/2248095-grief-over-covid-19-deaths-may-be-unusually-severe-and-long-lasting/

https://www.azdhs.gov/documents/preparedness/epidemiology-disease-control/infectious-disease-epidemiology/novel-coronavirus/sdmac/covid-19-addendum.pdf

Kapatel, P. M., & Malik, N. ara. (2020). Probable immersions for novel Coronavirus and its preventions: A systematic review [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/y34uv

Ip, A., Ahn, J., Zhou, Y., Goy, A. H., Hansen, E., Pecora, A. L., Sinclaire, B. A., Bednarz, U., Marafelias, M., Mathura, S., Sawczuk, I. S., Underwood, J. P., Walker, D. M., Prasad, R., Sweeney, R. L., Ponce, M. G., LaCapra, S., Cunningham, F. J., Calise, A. G., … Goldberg, S. L. (2020). Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: A multi-center observational study. MedRxiv, 2020.08.20.20178772. https://doi.org/10.1101/2020.08.20.20178772

The New York Times (2020) C.D.C. Halts Evictions, Citing Covid-19 Risks. Retrieved from: https://www.nytimes.com/2020/09/01/world/covid-19-coronavirus.html?action=click&module=Top%20Stories&pgtype=Homepage#link-26bc7ab3

Gorey, C. (2020, June 29). RCSI team to start trial for promising Covid-19 therapy for severe infections. Silicon Republic. https://www.siliconrepublic.com/innovation/rcsi-trial-covid-19-therapy-alpha-1-antitrypsin

Ferreira, L. M. R., & Mostajo-Radji, M. A. (2020). Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/cyqx8

Hogan, A. B., Jewell, B. L., Sherrard-Smith, E., Vesga, J. F., Watson, O. J., Whittaker, C., Hamlet, A., Smith, J. A., Winskill, P., Verity, R., Baguelin, M., Lees, J. A., Whittles, L. K., Ainslie, K. E. C., Bhatt, S., Boonyasiri, A., Brazeau, N. F., Cattarino, L., Cooper, L. V., … Hallett, T. B. (2020). Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: A modelling study. The Lancet Global Health, 0(0). https://doi.org/10.1016/S2214-109X(20)30288-6

Nature. (2020, April 17). Coronapod: Troubling news. https://play.acast.com/s/nature/coronapod-troublingnews

July 22, J. H. M. 2020 A.-493 P. O. F., & DOI 10.12788/jhm.3497, 2020 |. (2020). Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19. Journal of Hospital Medicine, 15(8). https://doi.org/10.12788/jhm.3497

The Lady’s Handbook for Her Mysterious Illness: A Memoir | IndieBound.org. (n.d.). Retrieved August 26, 2020, from https://www.indiebound.org/book/9780385534079

Peeters, A., Mullins, G., Becker, D., Orellana, L., & Livingston, P. (2020). COVID-19’s impact on Australia’s health research workforce. The Lancet, 396(10249), 461. https://doi.org/10.1016/S0140-6736(20)31533-6

Ophir, Yaakov, and Yaffa Shir Raz. ‘Manipulations and Spins in Attention Disorders Research: The Case of ADHD and COVID-19’. Preprint. PsyArXiv, 20 August 2020. https://doi.org/10.31234/osf.io/dmu4j.

Califf, Robert M., Adrian F. Hernandez, and Martin Landray. ‘Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments: Observational Cacophony, Randomized Harmony’. JAMA 324, no. 7 (18 August 2020): 625–26. https://doi.org/10.1001/jama.2020.13319.

Wang, C., Wang, S., Chen, Y., Zhao, J., Han, S., Zhao, G., Kang, J., Liu, Y., Wang, L., Wang, X., Xu, Y., Wang, S., Huang, Y., Wang, J., & Zhao, J. (2020). Membrane Nanoparticles Derived from ACE2-rich Cells Block SARS-CoV-2 Infection. BioRxiv, 2020.08.12.247338. https://doi.org/10.1101/2020.08.12.247338

Chen, Y., Yang, W.-H., Huang, L.-M., Wang, Y.-C., Yang, C.-S., Liu, Y.-L., Hou, M.-H., Tsai, C.-L., Chou, Y.-Z., Huang, B.-Y., Hung, C.-F., Hung, Y.-L., Chen, J.-S., Chiang, Y.-P., Cho, D.-Y., Jeng, L.-B., Tsai, C.-H., & Hung, M.-C. (2020). Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 main protease by tafenoquine in vitro. BioRxiv, 2020.08.14.250258. https://doi.org/10.1101/2020.08.14.250258

Godfred-Cato, S. (2020). COVID-19–Associated Multisystem Inflammatory Syndrome in Children—United States, March–July 2020. MMWR. Morbidity and Mortality Weekly Report, 69. https://doi.org/10.15585/mmwr.mm6932e2

Mohammadi, A., Esmaeilzadeh, E., Li, Y., Bosch, R. J., & Li, J. Z. (2020). SARS-CoV-2 detection in different respiratory sites: A systematic review and meta-analysis. EBioMedicine, 0(0). https://doi.org/10.1016/j.ebiom.2020.102903

Sherrard-Smith, E., Hogan, A. B., Hamlet, A., Watson, O. J., Whittaker, C., Winskill, P., Ali, F., Mohammad, A. B., Uhomoibhi, P., Maikore, I., Ogbulafor, N., Nikau, J., Kont, M. D., Challenger, J. D., Verity, R., Lambert, B., Cairns, M., Rao, B., Baguelin, M., … Churcher, T. S. (2020). The potential public health consequences of COVID-19 on malaria in Africa. Nature Medicine, 1–6. https://doi.org/10.1038/s41591-020-1025-y

Mather, N. (2020). How we accelerated clinical trials in the age of coronavirus. Nature, 584(7821), 326–326. https://doi.org/10.1038/d41586-020-02416-z

Jiang. L.Tang. K. Levin. M. Irfan. O. Morris. S. (2020) COVID-19 and multisystem inflammatory syndrome in children and adolescents. The Lancet Infectious Diseases. Retrieved from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30651-4/fulltext

Manski, C. F., & Tetenov, A. (2020). Statistical Decision Properties of Imprecise Trials Assessing COVID-19 Drugs (Working Paper No. 27293; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27293

Ou, T., Mou, H., Zhang, L., Ojha, A., Choe, H., & Farzan, M. (2020). Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2. BioRxiv, 2020.07.22.216150. https://doi.org/10.1101/2020.07.22.216150

Kominers, S. D., Pathak, P. A., Sönmez, T., & Ünver, M. U. (2020). Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design (Working Paper No. 27143; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27143

Horby, P., Mafham, M., Linsell, L., Bell, J. L., Staplin, N., Emberson, J. R., Wiselka, M., Ustianowski, A., Elmahi, E., Prudon, B., Whitehouse, A., Felton, T., Williams, J., Faccenda, J., Underwood, J., Baillie, J. K., Chappell, L., Faust, S. N., Jaki, T., … Landray, M. J. (2020). Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. MedRxiv, 2020.07.15.20151852. https://doi.org/10.1101/2020.07.15.20151852

Field, S. M., Hoek, J. M., de Vries, Y. A., Linde, M., Pittelkow, M., Muradchanian, J., & van Ravenzwaaij, D. (2020, July 30). Rethinking Remdesivir for COVID-19: A Bayesian Reanalysis of Trial Findings. https://doi.org/10.31222/osf.io/2kam7

Vaughan, A. (n.d.). Which covid-19 treatments work and how close are we to getting more? New Scientist. Retrieved 31 July 2020, from https://www.newscientist.com/article/2250176-which-covid-19-treatments-work-and-how-close-are-we-to-getting-more/

Sun, J., Zhuang, Z., Zheng, J., Li, K., Wong, R. L.-Y., Liu, D., Huang, J., He, J., Zhu, A., Zhao, J., Li, X., Xi, Y., Chen, R., Alshukairi, A. N., Chen, Z., Zhang, Z., Chen, C., Huang, X., Li, F., … Zhao, J. (2020). Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. https://doi.org/10.1016/j.cell.2020.06.010

Maarten van Smeden en Twitter: “Promising findings and very wide confidence intervals: the truth is usually not somewhere in the middle” / Twitter. (n.d.). Twitter. Retrieved July 24, 2020, from https://twitter.com/MaartenvSmeden/status/1285348767579938816

Studies show coronavirus antibodies may fade fast, raising questions about vaccines. (2020, July 17). SFChronicle.Com. https://www.sfchronicle.com/health/article/With-coronavirus-antibodies-fading-fast-focus-15414533.php

Sehgal, D. (2020). Analysis of Vaccines to tackle COVID-19 with Patent Review [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/q96wj

New Scientist on Twitter: “Thread on #covid19 trends in the US: Coronavirus infections have surged since the start of June from around 20,000 new cases a day to over 60,000. (1/4) https://t.co/wVFwHWczYR” / Twitter. (n.d.). Twitter. Retrieved July 19, 2020, from https://twitter.com/newscientist/status/1283387188391149571

Page, M. L. (n.d.). Why are US coronavirus deaths going down as covid-19 cases soar? New Scientist. Retrieved July 19, 2020, from https://www.newscientist.com/article/2248813-why-are-us-coronavirus-deaths-going-down-as-covid-19-cases-soar/

Lang, T. (2020). Plug COVID-19 research gaps in detection, prevention and care. Nature, 583(7816), 333–333. https://doi.org/10.1038/d41586-020-02004-1

Davies, R. (2020, July 16). Number of UK problem gamblers seeking help soars in lockdown. The Guardian. https://www.theguardian.com/society/2020/jul/16/lockdown-sparked-huge-upsurge-in-uk-problem-gamblers-seeking-help

Rosendaal, F. R. (2020). Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949. International Journal of Antimicrobial Agents, 106063. https://doi.org/10.1016/j.ijantimicag.2020.106063

Song, S. (2020). China Experience in Controlling COVID-19. https://doi.org/10.31235/osf.io/gfnep

Harvey, A., Armstrong, C. C., Callaway, C. A., Gumport, N. B., & Gasperetti, C. E. (2020). COVID-19 Prevention via the Science of Habit Formation [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/57jyg

Jena, A. B., & Worsham, C. M. (2020, June 30). What Coronavirus Researchers Can Learn From Economists. The New York Times. https://www.nytimes.com/2020/06/30/upshot/coronavirus-economists-dexamethasone.html

Man handcuffed in his own home.

Fuhrer, J., & Cova, F. (2020). “Quick and dirty”: Intuitive cognitive style predicts trust in Didier Raoult and his hydroxychloroquine-based treatment against COVID-19. https://doi.org/10.31234/osf.io/ju62p

Meyer, B., Torriani, G., Yerly, S., Mazza, L., Calame, A., Arm-Vernez, I., Zimmer, G., Agoritsas, T., Stirnemann, J., Spechbach, H., Guessous, I., Stringhini, S., Pugin, J., Roux-Lombard, P., Fontao, L., Siegrist, C.-A., Eckerle, I., Vuilleumier, N., & Kaiser, L. (2020). Validation of a commercially available SARS-CoV-2 serological immunoassay. Clinical Microbiology and Infection, 0(0). https://doi.org/10.1016/j.cmi.2020.06.024